Notably, tumor ECs were featured by upregulation of angiogenesis-related genes including collagens (e.g., COL4A1, COL4A2), PXDN, SPARC and HSPG2, as well as proliferation markers (e.g., MKI67, TOP2A) (Fig. 6I). The gene discussed is PXDN; the disease is neoplasm.